FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220838081> ?p ?o ?g. }

• W4220838081 abstract "Vitamin K antagonists (VKA) such as warfarin or phenprocoumon have been the mainstay of therapy for long-term oral anticoagulant therapy (OAT) in patients with atrial fibrillation or with pulmonary embolism. Due to interferences with matrix Gla-protein, an important vitamin K-dependent local calcification inhibitor in cardiovascular structures, VKA antagonists stimulate cardiovascular calcification (CVC). In contrast, rivaroxaban, a nonvitamin K-dependent oral anticoagulant (NOAC), should be neutral in terms of CVC. We seek to investigate these potential differences in CVC development between VKA versus NOACs in a randomized controlled trial (RCT).The influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism trial (NCT02066662) is a multicenter, prospective RCT with a two-arm, open-label study design. The primary endpoint is the progression of coronary and aortic valve calcification (quantified as calcification volume score) as assessed by cardiac computed tomography (CT) at 24 months in patients either treated by rivaroxaban or VKA. A total of 192 patients were randomized in a 1:1 fashion. The main inclusion criteria were the presence of atrial fibrillation and/or pulmonary embolism with the indication for OAT and pre-existent coronary calcification. The development of CVC will be assessed by follow-up CT at 12 and 24 months.In total 192 patients (median age 70, 72% male) were enrolled over a period of 5 years and followed up for 2 years." @default.
• W4220838081 created "2022-04-03" @default.
• W4220838081 creator A5001027249 @default.
• W4220838081 creator A5007468853 @default.
• W4220838081 creator A5010753998 @default.
• W4220838081 creator A5010910180 @default.
• W4220838081 creator A5019976194 @default.
• W4220838081 creator A5027966081 @default.
• W4220838081 creator A5044807719 @default.
• W4220838081 creator A5056180665 @default.
• W4220838081 creator A5064095889 @default.
• W4220838081 creator A5067488322 @default.
• W4220838081 creator A5068189118 @default.
• W4220838081 creator A5069853912 @default.
• W4220838081 creator A5070811893 @default.
• W4220838081 creator A5086344829 @default.
• W4220838081 date "2022-03-25" @default.
• W4220838081 modified "2023-10-08" @default.
• W4220838081 title "Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism" @default.
• W4220838081 cites W1517490828 @default.
• W4220838081 cites W1619629263 @default.
• W4220838081 cites W1809577636 @default.
• W4220838081 cites W1968985960 @default.
• W4220838081 cites W1999468381 @default.
• W4220838081 cites W2001994991 @default.
• W4220838081 cites W2014951154 @default.
• W4220838081 cites W2033676224 @default.
• W4220838081 cites W2058579856 @default.
• W4220838081 cites W2064239411 @default.
• W4220838081 cites W2084790107 @default.
• W4220838081 cites W2095804181 @default.
• W4220838081 cites W2095903478 @default.
• W4220838081 cites W2096837196 @default.
• W4220838081 cites W2097854437 @default.
• W4220838081 cites W2101432029 @default.
• W4220838081 cites W2117508965 @default.
• W4220838081 cites W2130199362 @default.
• W4220838081 cites W2153785016 @default.
• W4220838081 cites W2156255102 @default.
• W4220838081 cites W2163307440 @default.
• W4220838081 cites W2170491971 @default.
• W4220838081 cites W2180920440 @default.
• W4220838081 cites W2313705116 @default.
• W4220838081 cites W2318270581 @default.
• W4220838081 cites W2619860299 @default.
• W4220838081 cites W2749380187 @default.
• W4220838081 cites W2806816780 @default.
• W4220838081 cites W2888425789 @default.
• W4220838081 cites W2888718529 @default.
• W4220838081 cites W2921268892 @default.
• W4220838081 cites W2936743721 @default.
• W4220838081 cites W2937457528 @default.
• W4220838081 cites W4220838081 @default.
• W4220838081 doi "https://doi.org/10.1002/clc.23819" @default.
• W4220838081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35332571" @default.
• W4220838081 hasPublicationYear "2022" @default.
• W4220838081 type Work @default.
• W4220838081 citedByCount "2" @default.
• W4220838081 countsByYear W42208380812022 @default.
• W4220838081 countsByYear W42208380812023 @default.
• W4220838081 crossrefType "journal-article" @default.
• W4220838081 hasAuthorship W4220838081A5001027249 @default.
• W4220838081 hasAuthorship W4220838081A5007468853 @default.
• W4220838081 hasAuthorship W4220838081A5010753998 @default.
• W4220838081 hasAuthorship W4220838081A5010910180 @default.
• W4220838081 hasAuthorship W4220838081A5019976194 @default.
• W4220838081 hasAuthorship W4220838081A5027966081 @default.
• W4220838081 hasAuthorship W4220838081A5044807719 @default.
• W4220838081 hasAuthorship W4220838081A5056180665 @default.
• W4220838081 hasAuthorship W4220838081A5064095889 @default.
• W4220838081 hasAuthorship W4220838081A5067488322 @default.
• W4220838081 hasAuthorship W4220838081A5068189118 @default.
• W4220838081 hasAuthorship W4220838081A5069853912 @default.
• W4220838081 hasAuthorship W4220838081A5070811893 @default.
• W4220838081 hasAuthorship W4220838081A5086344829 @default.
• W4220838081 hasBestOaLocation W42208380812 @default.
• W4220838081 hasConcept C126322002 @default.
• W4220838081 hasConcept C164705383 @default.
• W4220838081 hasConcept C168563851 @default.
• W4220838081 hasConcept C2776265017 @default.
• W4220838081 hasConcept C2776301958 @default.
• W4220838081 hasConcept C2776704044 @default.
• W4220838081 hasConcept C2778661090 @default.
• W4220838081 hasConcept C2779161974 @default.
• W4220838081 hasConcept C2780309369 @default.
• W4220838081 hasConcept C71924100 @default.
• W4220838081 hasConceptScore W4220838081C126322002 @default.
• W4220838081 hasConceptScore W4220838081C164705383 @default.
• W4220838081 hasConceptScore W4220838081C168563851 @default.
• W4220838081 hasConceptScore W4220838081C2776265017 @default.
• W4220838081 hasConceptScore W4220838081C2776301958 @default.
• W4220838081 hasConceptScore W4220838081C2776704044 @default.
• W4220838081 hasConceptScore W4220838081C2778661090 @default.
• W4220838081 hasConceptScore W4220838081C2779161974 @default.
• W4220838081 hasConceptScore W4220838081C2780309369 @default.
• W4220838081 hasConceptScore W4220838081C71924100 @default.
• W4220838081 hasFunder F4320307771 @default.
• W4220838081 hasLocation W42208380811 @default.
• W4220838081 hasLocation W42208380812 @default.
• W4220838081 hasLocation W42208380813 @default.

• next